As of 2025-06-29, the Fair Value of Kolon TissueGene Inc (950160.KQ) is -1,954.77 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 41,500.00 KRW, the upside of Kolon TissueGene Inc is -104.71%.
With the market price of 41,500.00 KRW and our fair value calculation, Kolon TissueGene Inc (950160.KQ) is not a good investment. Investing in 950160.KQ stocks now will result in a potential loss of 104.71%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -35.41 | -41.39 | -8.62 | -13.19 | -24.78 | -24.68 |
| YoY growth | 16.23% | -16.89% | 79.18% | -53.08% | -87.80% | -12.47% |
| Market Cap (mil) | 3,758,250.00 |
| P/E | |
| Forward P/E |
| EPS | -0.29 |
| Avg earnings growth rate | -12.47% |
| TTM earnings | -25.95 |